Traditional Chinese medicine for treatment of inclusion body myositis

Abstract

The invention discloses a traditional Chinese medicine for treatment of inclusion body myositis. The traditional Chinese medicine is composed of Chinese herbal medicines basil, lonicera japonica, folium isatidis, Salvia plebeian, anemarrhena, mung bean hull, Terminalia chebula, Prunella vulgaris, Chinese Siphonostegia Herb, phellodendron, Suberect Spatholobus Stem, Palembus dermestoides, Gynura japonica, rhizoma corydalis, leech, luffa stem, Rhizoma Drynariae and rhubarb. The traditional Chinese medicine for treatment of inclusion body myositis provided by the invention adopts pure natural Chinese herbal medicines as the raw materials, can treat both symptoms and root causes, and has the characteristics of exact curative effect, no toxic or side effect, and difficult relapse.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine for treating inclusion body myositis. Background technique [0002] Inclusion body myositis is a chronic inflammatory myopathy. The main pathological feature is that there are tubular filament inclusion bodies in the sarcoplasm or muscle nucleus. Inclusion body myositis has an insidious onset and slow progression. About 70% of the first symptoms are proximal weakness of the lower limbs, and the onset may also be uniform weakness of the distal lower limbs, upper limbs, or all four limbs. Muscle weakness can be symmetrical or asymmetrical. As the disease progresses, distal muscle weakness can reach 50%, but only 35% of the patients have distal weakness that reaches or exceeds proximal weakness. The most affected muscles are the biceps, triceps, iliopsoas, quadriceps, and tibialis anterior, while the deltoids, pectoralis major, interosseo...

AI Technical Summary

Problems solved by technology

Tried plasma exchange therapy but the effect was not satisfactory